APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchLow Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b include Takeda, Xencor, Inc., MacroGenics, Inc. and BioInvent International AB, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b, also provides the revenue of main regions and countries. Of the upcoming market potential for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b revenue, projected growth trends, production technology, application and end-user industry.

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Company

Takeda

Xencor, Inc.

MacroGenics, Inc.

BioInvent International AB

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Type

BI-1206

MGD-010

SM-201

XmAb-7195

Others

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Application

Hospital

Clinic

Others

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BI-1206 Major Player Table 3. MGD-010 Major Player Table 4. SM-201 Major Player Table 5. XmAb-7195 Major Player Table 6. Others Major Player Table 7. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Clinic Major Player Table 10. Others Major Player Table 11. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Trends Table 12. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Drivers Table 13. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Opportunities and Challenges Table 14. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Restraints Table 15. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Share by Region (2021-2026) Table 18. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Share by Region (2027-2032) Table 20. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Players (2021-2026) Table 22. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Key Players Headquarters & Area Served Table 24. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players, Product Type & Application Table 25. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Type (2021-2026) Table 32. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Type (2027-2032) Table 33. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Application (2021-2026) Table 37. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Application (2027-2032) Table 38. Takeda Company Information Table 39. Takeda Business Overview Table 40. Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 42. Takeda Recent Development Table 43. Xencor, Inc. Company Information Table 44. Xencor, Inc. Business Overview Table 45. Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 47. Xencor, Inc. Recent Development Table 48. MacroGenics, Inc. Company Information Table 49. MacroGenics, Inc. Business Overview Table 50. MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 52. MacroGenics, Inc. Recent Development Table 53. BioInvent International AB Company Information Table 54. BioInvent International AB Business Overview Table 55. BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 57. BioInvent International AB Recent Development Table 58. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 59. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 60. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 61. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 62. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 63. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026) & (US$ Million) Table 64. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (US$ Million) & (2027-2032) Table 65. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 66. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 67. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 68. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 69. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (US$ Million) & (2027-2032) Table 72. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 73. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 74. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 75. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 76. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 77. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 78. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 79. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 80. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Region (US$ Million) & (2021-2026) Table 82. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Region (US$ Million) & (2027-2032) Table 83. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026) & (US$ Million) Table 84. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032) & (US$ Million) Table 85. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026) & (US$ Million) Table 86. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032) & (US$ Million) Table 87. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026) & (US$ Million) Table 89. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (US$ Million) & (2027-2032) Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Image Figure 2. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Share 2021 VS 2025 VS 2032 Figure 4. BI-1206 Image Figure 5. MGD-010 Image Figure 6. SM-201 Image Figure 7. XmAb-7195 Image Figure 8. Others Image Figure 9. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size (US$ Million) & (2021-2032) Figure 15. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Type (2021-2032) Figure 22. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Application (2021-2032) Figure 25. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032) Figure 27. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032) Figure 28. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Country (2021-2032) Figure 29. United States Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032) Figure 34. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032) Figure 35. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Country (2021-2032) Figure 36. Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032) Figure 46. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032) Figure 47. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032) Figure 49. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032) Figure 50. Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Region (2021-2032) Figure 51. Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032) Figure 59. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032) Figure 60. SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Country (2021-2032) Figure 61. Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • BI-1206
  • MGD-010
  • SM-201
  • XmAb-7195
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda
  • Xencor, Inc.
  • MacroGenics, Inc.
  • BioInvent International AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Type
  3. 1.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BI-1206
  5. 1.2.3 MGD-010
  6. 1.2.4 SM-201
  7. 1.2.5 XmAb-7195
  8. 1.2.6 Others
  9. 1.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Application
  10. 1.3.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Dynamics
  1. 2.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Trends
  2. 2.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Drivers
  3. 2.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Opportunities and Challenges
  4. 2.4 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Perspective (2021-2032)
  2. 3.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Growth Trends by Region
  3. 3.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Region (2021-2026)
  5. 3.2.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Players
  2. 4.1.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Players (2021-2026)
  3. 4.1.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Key Players Headquarters & Area Served
  7. 4.4 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players, Product Type & Application
  8. 4.5 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market CR5 and HHI
  11. 4.6.3 2025 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Tier 1, Tier 2, and Tier 3
5 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Type
  1. 5.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 5.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Type (2021-2032)
6 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size by Application
  1. 6.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  3. 6.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Xencor, Inc.
  8. 7.2.1 Xencor, Inc. Company Information
  9. 7.2.2 Xencor, Inc. Business Overview
  10. 7.2.3 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  12. 7.2.5 Xencor, Inc. Recent Developments
  13. 7.3 MacroGenics, Inc.
  14. 7.3.1 MacroGenics, Inc. Company Information
  15. 7.3.2 MacroGenics, Inc. Business Overview
  16. 7.3.3 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  18. 7.3.5 MacroGenics, Inc. Recent Developments
  19. 7.4 BioInvent International AB
  20. 7.4.1 BioInvent International AB Company Information
  21. 7.4.2 BioInvent International AB Business Overview
  22. 7.4.3 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  24. 7.4.5 BioInvent International AB Recent Developments
8 North America
  1. 8.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (2021-2032)
  2. 8.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 8.2.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026)
  4. 8.2.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032)
  5. 8.3 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032)
  6. 8.4 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  7. 8.4.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026)
  8. 8.4.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032)
  9. 8.5 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032)
  10. 8.6 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country
  11. 8.6.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026)
  13. 8.6.3 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (2021-2032)
  2. 9.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 9.2.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026)
  4. 9.2.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032)
  5. 9.3 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032)
  6. 9.4 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  7. 9.4.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026)
  8. 9.4.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032)
  9. 9.5 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032)
  10. 9.6 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country
  11. 9.6.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026)
  13. 9.6.3 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (2021-2032)
  2. 10.2 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 10.2.1 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026)
  4. 10.2.2 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032)
  5. 10.3 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032)
  6. 10.4 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  7. 10.4.1 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026)
  8. 10.4.2 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032)
  9. 10.5 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (2021-2032)
  2. 11.2 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 11.2.1 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026)
  4. 11.2.2 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032)
  5. 11.3 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032)
  6. 11.4 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  7. 11.4.1 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026)
  8. 11.4.2 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032)
  9. 11.5 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032)
  10. 11.6 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country
  11. 11.6.1 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026)
  13. 11.6.3 Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (2021-2032)
  2. 12.2 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Type (2027-2032)
  5. 12.3 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Application (2027-2032)
  9. 12.5 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country
  11. 12.6.1 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst